TESSERA DEFENSE AND HOMELAND
HLSQNYSE AMERICANTrading Snapshot
- Day Range
- $0.43 – $0.45
- 52-Week Range
- $0.44 – $2.16
- Volume
- $3.27B
- Avg Volume
- $3.42B
- Shares Outstanding
- 2.7M
- Next Earnings
- Oct 22, 2026
Fundamentals Snapshot
- Annual Revenue
- $77,088
- Last Q Revenue
- $18,032
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Why Investors Own HLSQ
- ✓High-growth profile — revenue up -7.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 65% gross margin and 15% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
TESSERA DEFENSE AND HOMELAND
HLSQ
StockOtter · stockotter.spaceAbout TESSERA DEFENSE AND HOMELAND
Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Dover, DE.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Tessera Sets 2027 Revenue Target of $14–16 Million and Outlines Path to Approximately $30 Million by 2029
Management believes that $14-$16 million of the 2027 revenue target will be supported by backlog, signed contracts or purchase orders, existing customer expansion, new customer, and additional commercial opportunities Ma
Tessera Obtains Option to Acquire Controlling Stake in RT LTA Systems, Adding Airborne Surveillance to Homeland Security Platform
NETANYA, Israel, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Tessera Defense and Homeland Security Inc. (NYSE American: HLSQ) (“Tessera” or the “Company”) today announced that it has been granted an option to acquire a majority i
Tessera Inc. Subsidiary Zorronet Ltd. Selected in Northern Israel AI Tender for up to $1.3 Million
Zorronet selected for AI-powered video analytics and access-control technology under framework agreement spanning a broad swathe of northern Israel Zorronet selected for AI-powered video analytics and access-control tech
UPDATE -- Tessera Defense and Homeland Security Inc. Increases Equity Investment Stake in M.E.A. Testing Systems
The investment for 15% stake in Motomea includes the advance of $475,000 convertible loan with exclusive option to acquire the remainder; secures license to MEA's drone testing technology The investment for 15% stake in
Tessera Defense and Homeland Security Inc. Amends Investment Agreement to Increase Stake in M.E.A. Testing Systems
The investment for an additional 5% gives Tessera a 15% stake in Motomea with exclusive option to acquire the remainder; secures license to MEA's drone testing technology The investment for an additional 5% gives Tessera
Tessera Defense and Homeland Security CEO Issues Letter to Shareholders
NETANYA, Israel, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Tessera Defense and Homeland Security Inc. (NYSE American: HLSQ) (“Tessera” or “the Company”) formerly BiomX Inc (NYSE American: PHGE), today released the following let